Elanco

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Elanco and other ETFs, options, and stocks.

About ELAN

Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. 

CEO
Jeffrey N. Simmons
CEOJeffrey N. Simmons
Employees
9,450
Employees9,450
Headquarters
Greenfield, Indiana
HeadquartersGreenfield, Indiana
Founded
1954
Founded1954
Employees
9,450
Employees9,450

ELAN Key Statistics

Market cap
10.63B
Market cap10.63B
Price-Earnings ratio
296.30
Price-Earnings ratio296.30
Dividend yield
Dividend yield
Average volume
6.26M
Average volume6.26M
High today
$21.95
High today$21.95
Low today
$21.05
Low today$21.05
Open price
$21.73
Open price$21.73
Volume
1.54M
Volume1.54M
52 Week high
$22.98
52 Week high$22.98
52 Week low
$8.02
52 Week low$8.02

Stock Snapshot

As of today, Elanco(ELAN) shares are valued at $21.41. The company's market cap stands at 10.63B, with a P/E ratio of 296.30.

As of 2025-11-06, Elanco(ELAN) stock has fluctuated between $21.05 and $21.95. The current price stands at $21.41, placing the stock +1.7% above today's low and -2.5% off the high.

The Elanco(ELAN)'s current trading volume is 1.54M, compared to an average daily volume of 6.26M.

During the past year, Elanco(ELAN) stock moved between $8.02 at its lowest and $22.98 at its peak.

During the past year, Elanco(ELAN) stock moved between $8.02 at its lowest and $22.98 at its peak.

ELAN News

TipRanks 15h
Elanco’s Q3 2025 Earnings Call Highlights Strong Growth

Elanco Animal Health ((ELAN)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI...

Seeking Alpha 21h
Elanco raises 2025 guidance to 6%–6.5% organic growth and $840M–$880M innovation revenue following strong Q3

Earnings Call Insights Elanco raises 2025 guidance to 6%–6.5% organic growth and $840M–$880M innovation revenue following strong Q3 Nov. 05, 2025 2:42 PM ET Ela...

Elanco raises 2025 guidance to 6%–6.5% organic growth and $840M–$880M innovation revenue following strong Q3
TipRanks 22h
Elanco price target raised to $27 from $23 at Stifel

Stifel raised the firm’s price target on Elanco (ELAN) to $27 from $23 and keeps a Buy rating on the shares. Elanco’s stock currently trades at a premium to Zoe...

Analyst ratings

69%

of 16 ratings
Buy
68.8%
Hold
25%
Sell
6.3%

More ELAN News

TipRanks 1d
Elanco raises FY25 adjusted EPS view to 91c-94c, consensus 91c

Raises FY25 revenue view to $4.65B-$4.67B from $4.57B-$4.62B, consensus $4.6B. Raises FY25 adjusted EBITDA view to $880M-$900M from $850M-$890M. “I am pleased t...

TipRanks 1d
Elanco sees Q4 adjusted EPS 9c-12c, consensus 14c

Sees Q4 revenue $1.09B-$1.11B, consensus $1.08B. Sees Q4 adjusted EBITDA $168M-$188M. The company said, “In the fourth quarter, Elanco (ELAN) expects a tailwind...

TipRanks 1d
Elanco reports Q3 EPS 19c, consensus 13c

Reports Q3 revenue $1.14B, consensus $1.09B. “Thank you to our global team and customers as Elanco (ELAN) delivered strong results ahead of expectations, with a...

People also own

Based on the portfolios of people who own ELAN. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.